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Abstract
Significance: Cellular redox processes are highly interconnected, yet not in equilibrium, and governed by a
wide range of biochemical parameters. Technological advances continue refining how specific redox processes
are regulated, but broad understanding of the dynamic interconnectivity between cellular redox modules re-
mains limited. Systems biology investigates multiple components in complex environments and can provide
integrative insights into the multifaceted cellular redox state. This review describes the state of the art in redox
systems biology as well as provides an updated perspective and practical guide for harnessing thousands of
cysteine sensors in the redoxome for multiparameter characterization of cellular redox networks.
Recent Advances: Redox systems biology has been applied to genome-scale models and large public datasets,
challenged common conceptions, and provided new insights that complement reductionist approaches. Ad-
vances in public knowledge and user-friendly tools for proteome-wide annotation of cysteine sentinels can now
leverage cysteine redox proteomics datasets to provide spatial, functional, and protein structural information.
Critical Issues: Careful consideration of available analytical approaches is needed to broadly characterize the
systems-level properties of redox signaling networks and be experimentally feasible. The cysteine redoxome is
an informative focal point since it integrates many aspects of redox biology. The mechanisms and redox
modules governing cysteine redox regulation, cysteine oxidation assays, proteome-wide annotation of the
biophysical and biochemical properties of individual cysteines, and their clinical application are discussed.
Future Directions: Investigating the cysteine redoxome at a systems level will uncover new insights into the
mechanisms of selectivity and context dependence of redox signaling networks. Antioxid. Redox Signal. 32,
659–676.
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Redox Systems Biology: Goals
The goal of redox systems biology, defined here asintegrative profiling or modeling aimed toward com-
prehensive, multiparameter understanding of the cellular
redox state, is to address the dimensionality and reductionist
challenges of redox biology. While systems biology often
does not test clear hypotheses, it is best suited to answer many
important redox questions that require an integrative solu-
tion. Is there a global redox setpoint or is each redox module
(Figs. 1 and 2) independent (2)? How can bottlenecks of
redox biochemistry be efficiently identified and confirmed in
cells, such as contexts in which nicotinamide adenine dinu-
cleotide phosphate (NADPH) or glutathione (GSH) becomes
limiting (92)? What are the design principles of redox sig-
naling and what distinguishes redox signaling from oxidative
stress (76)? What specific roles does redox biology play as a
hallmark of cancer (65) and other diseases? What sets redox
homeostatic setpoints, what triggers their adaptation in can-
cer and other diseases (35), and how can therapeutic inter-
vention restore them? How personalized or individualized are
redox processes? What are the key buffers between redox
modules enabling regulatory specificity and providing con-
text dependence to redox signaling networks?
Departments of 1Medicine and 2Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
3Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
ANTIOXIDANTS & REDOX SIGNALING
Volume 32, Number 10, 2020
ª Mary Ann Liebert, Inc.
DOI: 10.1089/ars.2019.7725
659
Broader goals of redox systems biology include generating
new hypotheses, defining the design principles of redox
signaling, and confronting common (mis)conceptions, which
are discussed throughout. One essential challenge for redox
systems biology is to supersede the ubiquitous ‘‘redox tri-
angle’’ model (Fig. 1a). In the redox triangle, the primary
driver of redox biology is the level of a vague redox stimulus,
usually inferred as reactive oxygen species (ROS) that directs
trinary outputs of cell steady state, signaling, and stress.
While simple, the triangle representation of redox biology is
misleading and puts a misplaced emphasis on ROS levels
(20) instead of circuitry, network logic, and cellular location.
Focusing on ROS levels, in turn, propagates the ‘‘antioxidant
paradoxes’’ of cancer, aging, and diabetes (9, 25, 109, 143).
Systems-level understanding of redox biology is a key to
accurately simplify visualization of the essential network
structures of redox biology (38) and to delineate and focus on
the functional regulatory nodes and circuitry based on spe-
cific cellular contexts.
Redox Biology: Systems-Level Challenges
Redox reactions are essential for life as key transducers of
cell signaling and metabolism. Redox processes are full of
contradiction, however, defying easily interpretable cause–
effect logic, and are often nonlinear, ultrasensitive, or hyster-
etic (55, 138, 163, 172). Discerning which redox module(s)
are responsible for a specific function or phenotype and de-
lineating how the module(s) function codependently with
other cellular components remain challenging. The inter-
connectivity crucial to the structure of cellular redox net-
works taxes the reductionist model of breaking down systems
into individual components to isolate a single root. Simpli-
fication is further hindered since many redox processes
cannot be accurately modeled outside of a cell (137), yet
within a cell there are many different redox processes that are
not in thermodynamic equilibrium (80) and vary across or-
ganelles (60) (Fig. 1b). Kinetic competition among many
reactions drives selectivity of redox processes, but adds an-
other layer of complexity that is difficult to model as simply
and intuitively as signal transduction and transcriptional
networks (2, 183). In addition, redox cycles occur on diverse
temporal scales since circadian rhythm, cell cycle, and light/
dark cycles alter cellular redox state over the course of hours
(39, 63, 167, 190), chronic diseases alter redox state over
FIG. 1. Redox systems biology: curse of
dimensionality. (a) The redox triangle is a
common representation of the cellular redox
state, with the Y-axis generally vague as is
typical. (b) Redox potentials (millivolts,
mV) vary widely between organelles and (c)
across temporal scales. (d) Cellular redox
components include redox couples, ROS
producers, redox active second messengers,
antioxidants, and redox effectors. ROS, re-
active oxygen species. Color images are
available online.
FIG. 2. Cysteines as sentinels of multiple redox mod-
ules: ROS, redox couples, cellular location and context,
and metabolism. Simplified network diagram of the redox
and nonredox inputs and outputs tuned to redox regulation
of the cysteine redoxome. Key proteins and molecules are
indicated. mito, mitochondria; ox, oxidized. Color images
are available online.
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months and years (57), yet significant perturbation to redox
homeostasis can be resolved in minutes or less to return to
steady state (28, 139) (Fig. 1c). The relationship and inter-
dependence of redox processes throughout the cell and across
different time scales remain poorly understood.
Cellular redox systems include a wide array of components
that are cooperative (190), but hierarchical and have varying
specificities and kinetics (Fig. 1d). These can be grouped into
five primary categories: (i) small molecule redox couples
(NADPH:NADP+, NADH:NAD+, GSH: oxidized glutathi-
one [GSSG]) that are often catalytically coupled to the ac-
tivity of (ii) antioxidant proteins such as peroxiredoxins
(PRDXs), thioredoxin (TRX), and GSH-utilizing enzymes.
(iii) Small metabolites often derived from oxygen such as
superoxide (O2
-), hydrogen peroxide (H2O2), and nitric
oxide (NO). Some of these play clear roles as signaling
second messengers but others, such as the hydroxyl radical,
lack the specificity or reversibility needed for signaling (48).
Hydrogen sulfide (H2S) and cysteine are small molecule ef-
fectors that participate in redox processes but do not use
oxygen (10, 17). (iv) The major endogenous sources of ROS
for redox signaling include NADPH oxidases (NOXs), dual
oxidases (DUOXs), nitric oxide synthases, and the mito-
chondrial electron transport chain. (v) The downstream ef-
fectors of redox biology, which may be directly or indirectly
redox regulated, include transcription factors such as nuclear
factor erythroid 2-related factor 2 (NRF2), hypoxia-inducible
factor 1-alpha (HIF1a), aryl hydrocarbon receptor, and nuclear
factor NF-kappa-B p100 subunit (NFjB), kinases such as
MAP kinases (MAPKs), and GTPases (68).
Redox biology suffers from the ‘‘curse of dimensionality’’
due to the many integrated components and high spatiotem-
poral diversity. While new chemical and imaging technolo-
gies with increased chemical (4, 120, 124, 125, 137, 139,
140) or spatiotemporal specificity (103, 137, 166, 193) have
unequivocally increased our knowledge of redox biology,
building of integrative, cell-level, bottom-up models of redox
biology with these narrowly focused techniques is experi-
mentally untenable (20, 177, 193). For example, the current
state of the art approach combining genetically encoded
sensors for NADPH:NADP+, NADH:NAD+, H2O2 levels,
and/or the thiol redox state in cells is limited by fluorescent
spectral overlap for each fluorophore, and thus each param-
eter must be measured in nonoverlapping cellular compart-
ments (193). Assaying additional spatial combinations of
redox processes requires generating new cell lines with a
different set of genetically encoded sensors. Using these tools
to approach a full accounting of the cellular redox state is
therefore experimentally challenging. ROS assays similarly
suffer from spectral limitations that restrict parallel analysis
of different ROS, localization, or other redox parameters. The
ability to introduce fluorophores with specific redox readouts
on demand would help alleviate these issues. Sallin et al. took
a step toward this goal by utilizing Snifit tags, biosensors of
cellular NAD+ levels, and the NADPH:NADP+ ratio, which are
semisynthetic and can be flexibly conjugated to target proteins
in live cells in real time similar to Halo- or SNAP tags (132).
Redox Systems Biology: Metabolism
Constraint-based mathematical modeling with flux bal-
ance analysis (FBA) is a common technique to simplify the
complexity of biochemical networks and predict the steady
state flux distribution of metabolites (116). FBA is especially
useful to determine the capacity of metabolic networks (41,
42, 45, 191) and narrow down possible model topologies (2,
116, 172) when combined with experimental results, in-
cluding public data. FBA coupled with carbon metabolite
tracing revealed that, unexpectedly, serine-driven 1-carbon
metabolism contributes as much to NADPH production as the
pentose phosphate shunt (PPP) via the activity of methyle-
netetrahydrofolate dehydrogenase (42).
A hallmark of redox processes is their dynamic, yet robust
mechanisms maintaining homeostasis (28, 66). Elucidating
how the cellular redox system transitions to respond to per-
turbations, transduces adaptive signaling, and either restores or
adjusts homeostasis remains an important challenge. To ex-
amine the mechanism of Escherichia coli’s rapid response to
stress, Christodoulou et al. quantified 30 metabolites at 10-s
intervals up to 1 min after stimulation with high levels of H2O2
(28). FBA of glycolysis and the PPP that leveraged publicly
available rate constants generated a candidate regulatory model
focused on a negative interaction between glucose-6-phosphate
dehydrogenase (G6PDH) and NADPH. The authors proposed,
and subsequently verified, that H2O2 stress decreases NADPH
levels within seconds, relieving NADPH-dependent inhibition
of G6PDH to increase flux through the PPP to restore NADPH
levels. This study highlights the robustness of the publicly
available redox kinetic data and the power of computational
modeling to in silico evaluate many potential redox compo-
nents and narrow the set of possibilities down to be feasible for
experimental testing. Kuehne et al. used time-resolved meta-
bolic profiling to demonstrate that the same NADPH–G6PDH
mechanism occurs in human fibroblasts in response to H2O2 or
ultraviolet stress (88). This mechanism is distinct from oxida-
tion of pyruvate kinase M2 C358, another redox-based mech-
anism inhibiting lower glycolysis to drive PPP flux and
NADPH production (7) that likely works on a longer time scale
to fine tune metabolism after it is restored initially by G6PDH
activation. Notably, as these studies all focus on modeling
oxidative stress, transitioning these systems-level approaches
to nonstress conditions in which H2O2 drives redox signaling
may reveal important new linkages between metabolic adap-
tation and sensors of redox alterations.
While the above studies focus on specific metabolic
pathways, the ultimate goal of redox systems biology is large-
scale prediction and characterization of redox modules (38).
Toward this goal, Lewis et al. modeled the NADPH-dependent
cycling of the chemotherapeutic b-lapachone in head and neck
cancer cells at the genome level using transcriptomic results
(92). After modifying the Recon 2 metabolite network to in-
clude all NADPH metabolic reactions, the authors performed
FBA of a network encompassing >5000 metabolites and 7000
reactions. Utilizing transcriptomic data from either matched
head and neck cancer cell lines or primary tumors in The
Cancer Genome Atlas that were either sensitive or resistant
to b-lapachone or radiation, the authors simulated the effect
of gene knockdown on drug sensitivity and predicted that
isocitrate dehydrogenase 1 (IDH1) played an especially
important role in NADPH production that mediated drug
resistance. These predictions were experimentally verified
by IDH1 knockdown in radiation-resistant cells, which
routed NADPH flux through glutamate dehydrogenase 1/2.
This study demonstrates the potential for genome-scale
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modeling of redox reactions in cell lines and primary tumors
using public data. It is especially exciting that specific
proteins and redox reactions that are limited by, or tuned to,
such a complex redox hub as NADPH can be predicted.
To date, most redox systems biology advances have been
limited to metabolism and use of mathematical modeling.
While FBA has clear utility, it has notable limitations, in-
cluding the inability to predict the dynamic changes in flux to
a stimulus since kinetic parameters are not incorporated
(116). Therefore, FBA only has limited ability to study redox
signaling, which is dynamic, or vastly altered metabolic
states that are not included in a generic map of human me-
tabolism such as those that occur during carcinogenesis. In
addition, constraints lie at the heart of FBA, and thus FBA
requires complete information for all reaction components
without any missing data. Protein expression therefore has
limited utility for FBA because proteomics datasets have
substantial amounts of missing data. Kinetic modeling is the
primary alternative to FBA for metabolic systems in appli-
cations where time-dependent dynamics are of interest (2,
181). Finally, since only the successfully verified mathe-
matical models are published, it is not possible to unbiasedly
gauge the overall accuracy of these approaches. Community-
wide, crowdsourced predictions such as DREAM challenges
(100) offer an important opportunity to gauge the effective-
ness of current mathematical redox modeling approaches.
Redox Systems Biology: Beyond Metabolism
Mathematical modeling and large-scale cysteine redox
profiling have provided insight into the hierarchic interde-
pendence of cellular antioxidant modules (83, 122, 123).
Modeling H2O2 clearance in Jurkat cells, Adimora et al.
discerned the relative contribution of various antioxidant
modules to buffer H2O2 and the percentage of proteins that
undergo S-glutathionylation versus disulfide formation (2).
While catalase accounted for <1% of H2O2 catabolism in
Jurkat cells, Benfeitas et al. modeled that catalase and
PRDXs contribute similarly to H2O2 metabolism in red blood
cells (16). Taking a different approach, Le Moan et al. and Go
et al. performed proteomic analysis of either yeast or mam-
malian cells, respectively, in which the TRX or GSH systems
were selectively impaired, both finding that each antioxidant
module controls the redox state of different subsets of cys-
teines in the proteome (58, 107). Systems-level metabolic
profiling also revealed a new metabolic pathway providing
cellular antioxidant capacity in normal hepatocytes that, de-
fying expectation, survive even in the absence of the activity
of two critical antioxidants, TRX and glutathione reductase
(GR) (41). Eriksson et al. discerned that methionine is able to
serve as the precursor of cysteine in TRX/GR-null livers, in
contrast to the canonical model in which cysteine is taken up
as its oxidized form cystine that is then reduced by the TRX/
GR system for use (41).
Redox systems biology techniques have facilitated devel-
opment of biosensors for high-throughput, single cell analysis
by identifying or directing evolution of NADPH-utilizing
proteins. Siedler et al. developed an NADPH biosensor based
on yellow fluorescent protein expression coupled to the SoxR
protein promoter that is activated by increased NADPH (144).
The authors performed a high-throughput, systematic screen of
NADPH-utilizing enzymes in large E. coli-mutant libraries to
identify novel variant proteins with increased NADPH uti-
lization that have potential application in metabolic engi-
neering. Zhang et al. similarly developed a growth selection
platform capable of screening 108 variants per round of
selection to identify NADPH-generating glyceraldehyde-3-
phosphate dehydrogenases with improved activity as well
as direct evolution of a Lactobacillus delbrueckii lactate
dehydrogenase variant with NADPH specificity instead of
NADH (192).
NRF2, NFjB, HIF1a, MAPK, and forkhead box proteins
constitute the master regulators of redox-sensitive transcrip-
tional networks (68). These proteins work in coordination to
initiate a transcriptional response that pleiotropically repro-
gram the cell’s redox homeostatic setpoint(s), not just a simple
upregulation of antioxidant capacity (68). In addition, sirtuins
are protein deacetylases that play a unique role in redox
biology by being tuned to NAD+ levels, capable of induc-
ing ROS production and regulating protein acetylation
(147). Application of systems biology beyond redox biology
has identified new regulatory architectures in which hyper-
connected master regulator proteins, via post-translational
regulation, serve as integrative controllers of vast transcrip-
tional networks in cell homeostasis, cancer, drug resistance (3,
23, 174). These master regulatory proteins stably maintain
complex phenotypes such as cancer despite the high genomic
and proteomic heterogeneity across tumors, but notably are not
frequently mutated or studied and difficult to identify using
conventional experiments (3, 23, 174). Application of these
computational techniques to redox biology may uncover new
redox regulator effectors that are responsible for higher level
organization and interconnection of redox modules.
Cysteines in the Proteome: Informative and Integrative
Redox Sentinels
All redox parameters would ideally be exhaustively and
quantitatively characterized in space, time, and abundance to
make a full accounting of the cellular redox status. However,
the requisite tools to do so are lacking, and the extensive
amount of time it would take to acquire all results with
quantitative accuracy limits feasibility. Tangible advancement
of redox systems biology will require careful consideration of
feature selection, data dimensionality reduction, and collection
of minimally redundant, maximally orthogonal data. For ex-
ample, how and when do ROS measurements provide value if
the sources and targets of the ROS are characterized, espe-
cially given the continued technical challenges of measuring
ROS and their limited mechanistic value (20, 40)? More
generally, how is the cellular redox state best assessed, and
what redox parameter(s) are most effective for modeling and
most efficiently determined experimentally?
Multiple properties of cysteines make them excellent and
relatively specific redox sentinels due to their thiol side chain
that can form seven stable oxidation states in vivo (56, 74,
127), which has been extensively reviewed (61, 70, 80, 127,
183). Experimental and bioinformatic analysis of the cys-
teine redoxome, defined as in Thamsen and Jakob (158) as
the composite of all redox active cysteines, can integratively
inform on many redox modules throughout the cell such as
specific types of ROS, redox couples, ROS producers, and
GSH-linked enzymes (80) (Fig. 2). For example, even in the
absence of imaging data, cysteine redoxome analysis can
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spatially delineate redox alterations at the plasma mem-
brane, mitochondria, and other organelles by examining
which sentinel proteins localized to each organelle are redox
regulated (Fig. 3).
Cysteines are oxidized by many ROS and redox effectors,
including O2
-, H2O2,
NO, H2S, Cys, and GSH, to form
specific adducts that can be selectively analyzed (4, 79, 117,
120, 124, 125, 133, 154). Recently, disulfide linkage between
cysteines and the sulfur in coenzyme A (S-CoAlation) di-
rectly linking cysteine oxidation to metabolism was found to
be a new cysteine redox modification established by
antibody-based assays and mass spectrometry (165). Analy-
sis of specific cysteine oxoforms can rapidly or comprehen-
sively assess global and spatial information on the state of
these second messenger effectors when coupled with gel-
based assays, microscopy, or proteomics. Cysteines in some
proteins can provide multiple levels of regulation such as the
PRDX family. Not only are different PRDX family members
spatially localized to distinct organelles, but the catalytic and
resolving cysteines are also highly tuned to H2O2. Thus,
analysis of the redox state of PRDX family cysteines can
inform on local H2O2 levels throughout the cell even without
microscopy or ROS assays (129).
There is strong evolutionary selection on cysteines. On one
hand, negative selection due to their intrinsic oxidizability
and reactivity has led cysteine to be the rarest amino acid.
Perhaps more insightfully, cysteine is also the most buried
amino acid despite its relative polar nature (101, 102). On the
other hand, when cysteines do arise during evolution they
typically carry a clear functional benefit and are seldom lost
later (171, 184). As cysteines are rare, buried, and highly
selected for specific function(s) in proteins, it follows that
each cysteine could be considered a unique sentinel tuned to a
set of context-specific factors informing on one or more redox
modules (18, 80) (Fig. 4). Conceptually, cysteines bridge the
systems–reductionist divide (151) since analysis of individ-
ual cysteines provides detailed biological information, but
the cysteine redoxome can provide a systems-level readout of
the cellular redox state when viewed globally. Notably,
cysteine redoxome analysis can link altered redox state with
specific proteins and biological pathways, which adds con-
siderable mechanistic value over other redox assays (20, 38).
Cysteine Redox Regulation: Properties and Mechanisms
of Specificity in Redox Signaling Networks
Properties of a cysteine affecting its oxidizability are
proximity to the source of ROS (183), low acid dissociation
constant (pKa) (22, 96, 183), and solvent accessibility (102),
which are necessary for direct interaction with a ROS. Redox
regulation can also occur without direct interaction with ROS
via disulfide relays (152, 161), transnitrosylation (64), or
protein translocation to an organelle with a different redox
setpoint (60). Notably, a subset of cysteines can be oxidized
even in the absence of global changes to the antioxidant
system (59) or detectable increase in ROS (20). This is due in
part to the limited sensitivity of ROS assays and because the
many endogenously redox-regulated cysteines are very re-
active and highly tuned to the local redox milieu.
The oxidizability of a cysteine also depends on its neigh-
bors. Kinetic competition, in which multiple potential reac-
tions vie for a use of a reactant, is an important mechanism of
FIG. 3. Protein sentinels of subcellular compartments. (a) Distribution of the number of organelles assigned by the
COMPARTMENTS database (19) to each human protein using the locations in (b). (b) Subcellular localization of all single
organelle-localized protein sentinels. (c) Cysteines in sentinel proteins can indicate localized redox regulation of specific
regulatory pathways. Color images are available online.
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redox selectivity in the complex cellular environment (2, 89,
183). For example, PRDXs are abundant proteins that are
highly reactive with H2O2, potentially outcompeting local
sulfenation of most other cysteines intracellularly (89, 149,
162, 170). Once oxidized, a PRDX can subsequently form a
disulfide relay with neighboring proteins in a relatively spe-
cific interaction (150, 152, 161). Thus, protein–protein in-
teractions also dictate redox regulation of a protein. Notably,
kinetic modeling of the PRDX2-STAT3 disulfide relay sug-
gests that its slow transfer kinetics are unfavorable in the
context of potential competing reactions in the cell (89). The
authors reconcile their results with published experimental
findings (149) by re-evaluating the PRDX disulfide relay
mechanism, and hypothesize that it may be facilitated by a
third, scaffolding component. Transnitrosylation has also
been reported to selectively relay a nitrosyl group from one
cysteine to another in a protein (111).
The oxidizability of cysteines also depends on the type of
ROS. For example, PRDXs are especially sensitive to H2O2,
whereas aconitase and other iron sulfur (Fe–S) cluster con-
taining proteins are more sensitive to O2
- (169, 179). Global
proteomic studies focused on analysis of specific cysteine
oxoforms have established that the selectivity of certain
cysteines for certain redox effectors is widespread, including
NO, GSH, and H2O2 (62).
While the magnitude of cysteine oxidation is generally
closely correlated with ROS levels, each cysteine oxoform
has unique kinetics and selectivity for individual cysteine
residues (138). Modeling the kinetics of cysteine sulfenic
acid (SOH) formation serves as an example, which explains
counterintuitive experimental results. Cysteine SOH is the
direct oxidation product of cysteine with H2O2. Therefore, a
priori, levels of H2O2 might be hypothesized to correlate
directly with levels of cysteine SOH (Fig. 5a). However,
empirically this is not observed; as increased exogenous
H2O2 and epidermal growth factor (EGF) stimulation results
in a biphasic change in SOH levels, increasing to a tipping
point, beyond which increased H2O2 decreases SOH levels
(120, 133). Kinetic modeling can explain these nonlinear,
counterintuitive results. Inclusion of cysteine sulfinic acid
(SO2H), the reaction product of SOH + H2O2, into the kinetic
model fits the observed biphasic response of SOH to H2O2
treatment (Fig. 5b). This example underscores how simple
network models can guide intuitive understanding of unex-
pected, but fundamentally important properties of redox bi-
ology as well as emphasizes that redox processes are rarely
linear. Importantly, while SOH levels do not parallel H2O2
levels, assaying sulfenation of the cysteine redoxome output
is potentially more meaningful as it indicates the transition
point of sulfenation to sulfination (SO2H) and more accu-
rately represents the oxidation of downstream H2O2 protein
effectors.
The design principles of cysteine redox networks are most
thoroughly understood by examining EGF signaling (Fig. 6),
the best characterized model of redox signaling (120, 188)
whose study was initiated by insulin receptor signaling de-
cades earlier (21, 33, 104). Growth factor signaling highlights
the importance of coordination to redox regulation, and in-
cludes both concerted oxidation of multiple cysteines in
proteins and codependence with redox-independent pro-
cesses to elicit specificity. The first principle is the impor-
tance of a spatially constrained source of ROS. In the case of
EGF, this is activation of NOX or DUOXs at the plasma
membrane (26, 60, 120). Second is the spatial specificity of
the O2
- and H2O2 produced by rapid intracellular degrada-
tion of ROS that limits their diffusion distance (95, 103, 120,
FIG. 4. Protein structural changes specify context-
dependent regulation of the cysteine redoxome and re-
dox signaling networks. (a) Cysteines are the targets of
oxidation and reduction, and in the canonical model cyste-
ines that are solvent accessible can be redox regulated. (b)
Recent studies (6, 15, 62) suggest that cryptic cysteines,
those that become solvent exposed only upon a stimulus,
can provide further context dependence of cysteine redox
regulation via redox-independent changes in protein struc-
ture. Color images are available online.
FIG. 5. Nonintuitive, nonlinear redox regulation of cysteine sulfenation by H2O2. (a) In a kinetic model including
only H2O2 and cysteine sulfenation (SOH), the concentrations of [H2O2] and [SOH] are directly related. While intuitive, this
does not fit the empirical results in which H2O2 is biphasic, increasing [SOH] up to a point, beyond which [SOH] decreases.
(b) Inclusion of cysteine sulfination (SO2H), the reaction product of SOH + H2O2, generates the observed biphasic rela-
tionship of [SOH] to [H2O2]. H2O2, hydrogen peroxide. Color images are available online.
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166). A third principle is the relatively short duration of al-
tered redox state before returning to homeostasis (66),
<60 min in the case of EGF stimulation (120). Fourth, oxi-
dation of multiple cysteines in several proteins is critical to
tipping the balance toward EGF-dependent phosphorylation.
Oxidation of the catalytic cysteine in protein tyrosine phos-
phatases decreases the brake on phosphotyrosine signaling
(46), and oxidation of cysteine in the kinase domain of epi-
dermal growth factor receptor (EGFR) increases its activity
up to a point, above which its kinase activity decreases (120).
Notably, there is selectivity in which phosphatases are oxi-
dized since EGF is a poor oxidizer of PTP1B yet oxidizes
SHP-2 at very low EGF levels (120). While there is no clear
mechanistic explanation for this, it is likely to be context-
dependent changes in the phosphatases rather than an intrinsic
property of the phosphatase(s) themselves since insulin pref-
erentially oxidizes PTP1B (67). A fifth design principle is the
interdependence of redox-dependent and -independent events
(15). EGF-dependent phosphotyrosine signaling occurs more
rapidly than redox processes, peaking *1 min after EGF
stimulation (32, 115), whereas ROS production and cysteine
SOH are delayed and maximal at 5 min (120). This delay is
setup because EGF-dependent phosphorylation of NOX by
SRC is required to trigger NOX activation and ROS produc-
tion. SRC-dependent phosphorylation of Y194 of PRDX1 also
locally deactivates it near the cell membrane (185), facilitating
local buildup of H2O2 levels (97, 185). From a network per-
spective, redox signaling serves as an amplifier, rather than
initiator, of EGF signaling, and the temporal delay of phos-
phatase and kinase regulation likely promotes ultrasensitivity
of EGF signaling, sharpening the response to become more
binary and less graded (72, 168).
The temporal separation of redox-independent and redox-
dependent events plays a key role in specifying which cys-
teines are oxidized by EGF due to an emerging relationship
between protein structure and oxidation of cryptic cysteines,
those that are only solvent exposed upon changes in protein
conformation (6, 15, 75, 86). It has been estimated that 40%–
70% of proteins are allosterically regulated and contain cryptic
pockets (29, 114), and several studies have found that changes
in protein folding can allosterically alter cysteine solvent ac-
cessibly (13, 53). Redox regulation of cryptic cysteines was
conclusively demonstrated by Alegre-Cebollada in which cell
stretching mechanically unfolded the elastic protein titin and
allowed several cysteines to become solvent exposed and
glutathionylated (6). Redox regulation inhibited titin refolding,
stabilizing the extended structure to impart a mechanically
weak state, which decreased cardiomyocytes stiffness (6).
More broadly, Gould et al. performed a redox proteomic
analysis of *3000 cysteines in mouse liver under steady state
physiological conditions, and found that the cysteines oxidized
at steady state had neither a low pKa nor were especially
solvent accessible (62). A similar conclusion was reached in
another large-scale profiling of redox-regulated cysteines (51).
While this could be due to inaccurate pKa predictions, a
similar prediction of the cysteines oxidized by H2O2 finds
them to be largely solvent accessible in several studies (53,
188). A likely explanation is that endogenous ROS oxidizes
cysteines that are solvent exposed at steady state, which is not
reflected in crystal structures that are biased toward stable low-
energy conformers (146). Once a cryptic cysteine is oxidized,
the surrounding apolar environment may stabilize it in the
oxidized state (163). Alternatively, it has been proposed that
hydrophobic NO may be able to tunnel to buried cysteines
surrounded by hydrophobic residues (18). Since most cyste-
ines are buried due to negative selection (101, 102), redox
regulation of cryptic cysteines provides a plausible mechanism
specifying the context-dependent selectivity of redox signaling
pathways (15) (Fig. 4).
Additional connections between protein structure and
cysteine oxidation are notable. Thiol/disulfide exchange in
proteins can be regulated by mechanical force and can be
influenced by protein folding (182). Second, forbidden dis-
ulfides with relatively high disulfide redox potential that in-
troduces strain into a protein’s structure occur in many protein
crystal structures and can serve as redox switches (43, 186).
a b c
FIG. 6. Temporal separation of redox-dependent and -independent events is a key design principle of the EGFR
signaling network. (a) Redox-dependent signaling is delayed from redox-independent signaling after EGF stimulation.
EGF initially stimulates local phosphotyrosine signaling cascades, an important activator of NOX and inhibitor of PRDX
activity, (b) delaying ROS production and spatially constraining the H2O2 produced to the plasma membrane. (c) Cysteines
in multiple proteins, including EGFR and PTPs, are concertedly redox regulated. EGF, epidermal growth factor; EGFR,
epidermal growth factor receptor; NOX, NADPH oxidase; PRDX, peroxiredoxin; PTP, protein tyrosine phosphatase. Color
images are available online.
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Together, the cysteine redoxome contains information
integrating protein structural dynamics, redox-dependent and
-independent regulation, as well as the location and levels of
redox perturbations (Figs. 2–4). From the perspective of bi-
ological network design (168), cysteines serve inter alia as
redox sniffers [transient responses, (149, 183, 185)], toggles
[hysteretic switches, (33)], amplifiers (120), blinkers [oscil-
lators, (38, 39)], and feedback loops (21, 68). Importantly,
cysteine oxidation, as compared with other assays, is un-
iquely suited to leverage new insights into the context de-
pendence of redox biology by directly linking to downstream
pathways. The next section details cysteine oxidation assays
and the tools available to maximally harness these results,
especially those from cysteine redox proteomics datasets.
Techniques to Assay Cysteine Redox Regulation
Numerous probes can directly and covalently tag specific
cysteine oxoforms such as SOH (120, 124, 125), SO2H (4),
persulfide (117), and SNOs (139). Incorporating a clickable
handle, such as an azide or alkyne, for one step conjugation to
a wide array of detection modalities facilitates protein puri-
fication as well as in situ and in vivo imaging (187). Analysis
of cysteine SOH oxoforms is the most mature, with SOH
probes enabling imaging (78, 120, 140) and detection of
>1000 sulfenated cysteines by proteomics (188). Proteomics
has also been performed using direct SNO probes (139).
While there is no probe to chemically label endogenous GSH,
cells can utilize biotinylated GSH ethyl ester in place of GSH
(Bio-GEE), as well as more flexible, clickable GSH analogs
(44, 79). Unfortunately, no technique is capable of labeling
disulfide bonds directly or indirectly, thus large-scale pro-
filing of the disulfideome is not currently feasible. However,
disulfide relay partners can be identified via catalytic mutants
that prevent resolution of the disulfide (112). One limitation
of cysteine oxoform trapping probes is their slow reactivity
and efficiency that, coupled with low endogenous modifica-
tion stoichiometry, often dictates long (30–60 min) incuba-
tion times (188) and limits their utility for temporal profiling
or assays that require substantial protein input. In addition,
the specificity of several oxoform-directed probes has been
questioned (47, 130, 160).
While trapping cysteine oxoforms with probes can be
coupled with mass spectrometry (62, 139, 188), most redox
proteomics utilize differential alkylation to tag all reversibly
oxidized cysteines (62, 70) or selectively reduce specific
oxoforms such as SNO (50, 62), S-GSH (37, 62), or persul-
fides (36). In the differential alkylation procedure, free thiols
are first covalently labeled with an alkylating reagent such as
iodoacetamide or N-ethylmaleimide (NEM), reversibly oxi-
dized cysteines are then reduced, followed by labeling the
now free cysteine thiols with a different alkylating agent to
distinguish previously oxidized thiols (70). While informa-
tion about specific oxoforms is often lost, the lack of selec-
tivity may be advantageous from a systems biology
perspective by being more inclusive and integrative. Differ-
ential alkylation studies also enable detection of more cys-
teines and thus more sentinels, casting a wider net that can be
more fully leveraged for functional analysis and spatial de-
termination of cellular redox changes (15, 62, 128). Fur-
thermore, since cells or tissues are rapidly lysed before
differential labeling, a rapid snapshot of the redox state is
acquired that enables assessment of cysteine oxidation dy-
namics with higher temporal precision compared with in situ
trapping with covalent oxoform-specific tags (15).
Cysteine redox proteomics has been applied to many
models, including oxidation analysis of *170 peptides
in Caenorhabditis elegans during development and aging
(87), *1200 cysteines in Drosophila melanogaster under
conditions of fasting and aging (105), *2100 cysteines in
Synechocystis spp. PCC 6803 in light versus dark cycles
(63), *2500 sites in mouse liver at steady state (62), and as
many as*4500 and*9500 cysteines in yeast and mouse cells,
respectively, upon oxidative stress (128). The magnitude of
oxidation of the cysteine redoxome by endogenous perturba-
tions is surprisingly widespread with *49% of cysteines de-
tected having altered redox regulation by endogenous
perturbation, including EGF stimulation, light–dark cycling, or
fasting (15, 63, 93, 188). Despite the utility of redox proteomics
to assess redox signaling, many redox proteomic studies con-
tinue to focus on models of oxidative stress (8, 27, 128, 173).
The cysteine proteome also contains reactivity and solvent
accessibility information that is complementary to redox
status. Cysteine protection assays have long been utilized to
determine protein structural changes (1). Bar-Peled et al.
adapted this approach to profile solvent accessible cysteines
proteome wide in cultured cells using high levels of alky-
lating agents to fully label cysteines (13). Alternatively,
Weerapana et al. utilized limiting doses of the alkylating
reagent iodoacetamide to quantify the nucleophilicity of
cysteine in the proteome (180). Nucleophilicity is correlated
with pKa but is nonlinearly related to oxidizability (163).
Petrova et al. profiled the reactivity of *6000 cysteines in
drosophila in the presence or absence of the ovary-specific
TRX Deadhead using a similar alkylation approach (121).
Redox systems biology, like other systems-level analyses,
is currently limited in practice more by the lack of data
availability than computational power (172). Unfortunately,
redox proteomics assays have limited throughput due to the
multiple steps in sample preparation and data analysis.
Therefore, generation of proteomic data is the primary bot-
tleneck to proteome-level characterization of cysteine senti-
nels in the redoxome. Analysis of multiple oxoforms (62)
expands the number of samples to analyzed, restricting the
number of conditions that can be profiled and limiting char-
acterization of the dynamics of the cysteine redoxome (176).
Isotope encoded, cysteine-reactive iodoTMT reagents capa-
ble of six-plex sample analysis can improve throughput of
sample analysis (8, 14, 118, 119, 141) and can be optionally
paired with N-terminally labeling TMT reagents to quantify
protein expression changes in parallel (14, 119). Pairing mat-
ched stable-isotope encoded variants of alkylating reagents
before and after reduction can estimate the oxidation stoi-
chiometry of each cysteine detected (63, 69, 70, 91, 145);
however, absolute percentage oxidation has limited bio-
logical inference, and thus relative changes in oxidation
levels are typically the focus of analysis.
Large-scale mass spectrometry-based proteomics are also
limited by the dynamic range, roughly three orders of mag-
nitude, which can be overcome by targeted mass spectrom-
etry assays to improve sensitivity (34, 69). Multiple reaction
monitoring mass spectrometry has been applied to quantify
targeted cysteines in many proteins (34, 69). While a
downside of targeted assays is quantitation of fewer analytes,
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new approaches using data-independent acquisition (DIA),
also known as SWATH, and retention time scheduling
analysis of targeted analytes across the liquid chromatogra-
phy (LC) profile dramatically increase the number of analytes
that can be measured in a single mass spectrometry run (15,
134). Notably, proteomic datasets using isobaric tags such as
TMT often have up to 50% of quantitative data points
missing. DIA mass spectrometry can quantify nearly all
analytes detected in a sample, but can be more challenging to
analyze (30, 71).
Bottom-up mass spectrometry-based proteomics often
does not detect key cysteines. For example, the catalytic
cysteines in protein tyrosine phosphatases and PRDXs are
rarely detected due to their placement in poor tryptic pep-
tides, low abundance, or low ionizability. Despite the prog-
ress of top-down proteomics (49), translating cysteine redox
proteomics assays to a pure top-down format has many
technologies hurdles. However, integration of top-down and
bottom-up proteomics proved useful for post-translational
modification (PTM) analysis of cancer samples and may in-
crease the completeness of redox proteomics datasets (113).
Alternatives to mass spectrometry-based proteomics, such as
immobilized antibody arrays, have been used to rapidly
profile the glutathionylation of 1000 proteins, many of them
typically below the detection limit of mass spectrometry as an
additional benefit (110). However, this approach is not able to
determine which specific cysteine residues are oxidized.
Feature selection is an important challenge in redox bi-
ology given its high data dimensionality. While orthogonal
assays, for example, temporal characterization and pro-
teomics, may be an ideal pair, integrating disparate datasets
can be challenging. Self-organizing maps have potential to
visualize and classify high dimensional data (52). Network
inference to conceptualize and simplify biological reality
using coexpression or transcription regulatory networks has
also shown promise (148), but for redox analyses these need
continued advancements to include information about redox
couples, PTMs, metabolites, and/or ROS. Thus, the most
efficient approach to understand the redox landscapes and the
network architecture of redox modules remains elusive.
Redox-Regulated Cysteines: Predicting and Annotating
Biochemical Properties
The large-scale, site-specific information provided by re-
dox proteomic analysis is advantageous for translating in-
formation about the cysteine redoxome to integrative
knowledge of the cellular redox state. While cysteine redox
profiling does not provide a full account of redox biology,
each analysis generates an enormous amount of data that can
be harnessed for multiparameter assessment of the redox state
of cells using relatively user-friendly tools. Characterizing
the properties of cysteine redox sentinels can be used to infer
spatial information or ROS regulation independent of mi-
croscopy or ROS assays, and is valuable for feature selection
and hypothesis generation. Available resources to annotate or
predict the properties of individual cysteines and redox-
regulated proteins are detailed here to maximize the infor-
mation content of each cysteine and utilize it as an individual
redox sensor. In some cases, this information is empirically
determined and publicly available, and in other cases the
properties require computational prediction. Tools that are
open source are prioritized whenever possible as are those
that are suitable for proteome-scale analysis, rather than
analysis of a single cysteine or protein at a time.
Quantitative redox proteomics methods universally pro-
teolyze proteins into peptides with trypsin before LC-mass
spectrometry analysis. Thus, the first step of proteomic data
analysis is assigning each peptide to a protein or proteins that
include the peptide amino acid sequence. In many cases,
peptides can be assigned to a single protein, but in some cases
multiple proteins share a single peptide sequence. Peptide
sequences shared between homologous genes, such as AKT
isoforms, may offer valuable biological information similar
to PTM-specific antibodies that cannot distinguish between
highly conserved regulatory sites within gene families. How-
ever, if the peptide is shared between two unrelated proteins
the peptide has far less utility. Most mass spectrometry-based
proteomic analysis software, such as the open source and well-
supported MaxQuant (31), will indicate all proteins that can be
assigned to a given peptide as well as the residue number of the
modified cysteine that can be carried forward for further
bioinformatic analysis.
Solvent accessibility and local protein domain information
are important components of cysteine redox regulation.
NetSurfP-2.0 uses deep learning to predict the relative sur-
face accessibility, secondary structure, and disorder of all
amino acids in a protein, and can process large batches of
protein inputs (84). UniProtKB is a large, curated, database
that contains and links to the naturally occurring and disease-
relevant variants of specific amino acids, known PTMs or role
in metal binding, as well as the protein domain containing
each cysteine. Since the entire UniProt database can be down-
loaded and readily parsed, it is amenable to proteome-wide
annotation.
Protein structures can also inform about the potential role
of cysteines. While visual analysis is necessarily low
throughput, protein crystal and solution state nuclear mag-
netic resonance structures can be found in the protein data
bank. Chimera is an open source and powerful visualization
tool for protein structure analysis that is integrated with
MODELLER to build homology models if no protein struc-
ture is available (189). Interactive, virtual reality visualiza-
tion of redox PTMs on proteins has recently been reported,
and is an exciting new option for protein visualization (98).
Finally, predicting the structural consequence of cysteine
oxidation using an existing crystal structure as a starting point
can be performed with Forcefield_PTM, a web-based tool
that includes many cysteine oxoforms (81). An important
caveat of all protein structure analyses, however, is that the
full extent of protein dynamics and modifications are not
represented.
Cysteine pKa, especially lowered pKa that can predispose
a cysteine for oxidation (22, 96, 183), is a key physico-
chemical property of each cysteine. A comparison of four
methods to predict pKa benchmarked to experimentally de-
termined values was recently evaluated, including the com-
monly used algorithm PROPKA (11). Unfortunately, all
methods were found to be unreliable with pH deviations
averaging 2.5–3 U from empirically observed values. Adding
to the challenge of pKa prediction, all currently available
tools are limited to analysis of a single protein structure. As
an alternative approach, pKa is correlated with nucleophi-
licity and reactivity (101, 102), which can be empirically
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determined on a large scale at the level of specific cysteines.
The reactivity of 1082 cysteines in breast cancer cell extracts
has been profiled (180), providing a large-scale, empirically
determined dataset as an alternative to pKa. These data, along
with other parameters, have facilitated sequence-based pre-
diction algorithms of cysteine reactivity and oxidizability
using machine learning (155, 175).
For protein localization annotation, UniProtKB references
the COMPARTMENTS database, which combines experi-
mental data, informatic predictions, and text mining (19).
Over 9400 canonical human proteins, accounting for 46% of
the human proteome, are annotated to a single major sub-
cellular organelle in the UniProtKB that can be used as lo-
cation sentinels of subcellular changes in redox state
(Fig. 3a). These sentinels are mostly localized to the nucleus
and cytoplasm, but numerous sentinels of even the peroxi-
some and endosome are annotated (Fig. 3b). The Human
Protein Atlas also provides localization information based on
antibody staining (159).
Numerous resources are available to assign the biological
role(s) and function(s) of redox-regulated proteins. Uni-
ProtKB offers a curated description of protein function. The
dependency map is generating genome-scale drug inhibition
and gene deletion datasets to assess the functional depen-
dency of genes in cancer models (164). Large-scale CRISPR
screens coupled with high content imaging and reporter gene
assays are being used to examine gene-dependent phenotypic
changes at the organelle level (142). Protein interaction
partners often provide orthogonal insight into the life of
protein. The STRING database includes protein–protein in-
teractions for *10 million proteins that are based on a
combination of in silico prediction, high-throughput experi-
ments, text mining, and coexpression information (156).
Alternatively, BioPlex is using high-throughput protein af-
finity purification mass spectrometry to empirically deter-
mine protein–protein interaction partners of >2000 bait
proteins to generate a list of 70,000 experimentally verified
protein–protein interactions (73). Full functional assessment
of redox-regulated cysteines often includes site-directed
mutagenesis, but this is a low-throughput approach that is
importantly not applicable to enzymes in which the cysteine
residue is directly involved in their activity (82, 85).
Pathway-level annotation of proteins can be performed
with protein set enrichment analysis (90). Alternatively,
peptides can be assigned to the gene level (178), and the more
commonly utilized gene set enrichment analysis (153) can be
used. Notably, since identification by proteomic technologies
is biased toward abundant proteins, such as metabolic and
ribosomal proteins, it is critical to include all detected pro-
teins in over-representation analysis. Specifically, inputting
list of significantly regulated proteins identified by pro-
teomics to investigate their enrichment compared with the
human proteome will provide minimally useful biological
insight. In addition, since proteomics datasets contain many
proteins, multiple-hypothesis correction of p-values by
Benjamini-Hochberg or another method should be consid-
ered for differential expression analysis. While protein in-
teraction maps can be difficult to meaningfully interpret,
network inference algorithms are a systems biology tool to
infer important subnetworks and focus analysis (99). Since
cysteine oxidation is a protein PTM event at the level of a
specific cysteine rather than a gene, pathway mapping of the
modified residues remains challenging though several tools are
pushing PTM pathway analysis forward (126, 131). While
there is no complete database of known redox-regulated sites,
ProteomeScout (108) and OXID (53) are large protein PTM
databases that include oxidized cysteine sites that can be
downloaded to determine which redox-regulated cysteines
identified may be novel. Other tools are available to predict
sites of cysteine sulfenation (5) and S-nitrosation (24).
Cysteine Oxidation in the Clinic
Antioxidant therapies have had mixed results in patients
due to many factors, including the relatively poor reactivity
of most antioxidants, a focus on ROS levels rather than redox
circuitry, and the lack of good biomarkers of drug activity
(25). Next generation redox therapeutic approaches targeting
the source of ROS, such as NOX (157), or targeting a specific
redox vulnerability of cancer cells with relatively nonspecific
antioxidants, such as ascorbate (135), provide continued
optimism for redox-based therapies.
Assaying the cysteine redoxome in vivo could provide
information on the mechanism of drug action, identify bio-
markers of drug efficacy, and delineate the altered redox
networks in individual patients to tailor redox-based thera-
peutic strategies (25). Key questions are whether the redox
state of a disease is personalized and whether it can be
drugged to restore homeostasis. The Cys:CySS ratio can
serve as a redox biomarker of cells, tissues, and plasma (61),
and served as a peripheral biomarker of treatment response in
epileptic rats treated with kainic acid or pilocarpine (94). For
in vivo analysis of Cys:CySS or GSH:GSSG, plasma samples
must be immediately alkylated to preserve the redox state and
to prevent artifacts during sample analysis (77). Oxidation of
serum albumin C34, its lone nondisulfide-linked cysteine that
is the major plasma oxidant sink, has also demonstrated po-
tential as a biomarker (12, 41). While only minimally inva-
sive, plasma analysis of redox couples or a single cysteine is
unlikely to provide much specificity about the underlying
disease biology or drug action. In comparison, cysteine
oxoform trapping probes coupled with positron emission
tomography imaging would allow noninvasive, in vivo
analysis of the cysteine redoxome with more information
content; however, this has not been reported to date.
Tissue biopsies offer more flexible options for cysteine
redox analysis though best results require consistent sample
processing after harvesting to minimize differential effects
due to hypoxia (106). The in vivo redox state of the thiol-
based roGFP, representative of the cysteine redoxome gen-
erally, has been shown to be accurately preserved after snap
freezing, cryosectioning, and immersion if the fast acting
alkylating agent NEM is added immediately to prevent ex
vivo oxidation by atmospheric oxygen or fixation (54). As
NEM alkylation is often the initial step of differential al-
kylation, downstream processing of tissue biopsies for bio-
chemical assays or proteomics is similarly technically sound
(70). While the dynamic nature of cysteine redox regulation
may limit their utility as biomarkers, the availability of
techniques to preserve their redox state likely makes them at
least as robust assay targets for in vivo analysis in the clinic as
ROS assays or redox couples. Development of new cysteine
analysis tools for patient samples is needed, such as anti-
bodies that recognize unique oxoforms localized to specific
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cysteine residues in target proteins that could be used for
immunohistochemistry or enzyme-linked immunosorbent
assay.
Drugs containing irreversible thiol reactive groups are
being incorporated into the next generation of targeted ther-
apies toward kinases EGFR or Bruton’s tyrosine kinase to
minimize drug resistance (136). Notably, it is estimated that
up to 20% of EGFR C797 is sulfenated (120). Since oxidation
of these cysteines blocks reactivity, the efficacy of these new
inhibitors may depend on the redox state of the cysteines and
assaying it may inform on drug efficacy.
Concluding Remarks
Redox signaling via cysteine sentinels plays a multifaceted
role in biology despite the biochemical complexity, tran-
sience, and likelihood for deleterious stress that a priori
seems insufficiently robust to be selected for critical cellular
tasks (190). The prevalence of cysteine redox regulation may
simply be an ancient, anachronistic holdover from the great
oxidation event (39) that persists as an inevitable conse-
quence of life or, rather, is sustained due to robust design
principles that are still being elucidated. New insights into
redox signaling and regulation of the cellular redox state can
be gleaned by harnessing the network of individual cysteines
in the redoxome as sensors of cellular redox state that bridges
reductionist and systems-level perspectives.
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EGF¼ epidermal growth factor
EGFR¼ epidermal growth factor receptor









HIF1a¼ hypoxia-inducible factor 1-alpha
IDH1¼ isocitrate dehydrogenase 1
LC¼ liquid chromatography
MAPK¼MAP kinase
NADPH¼ nicotinamide adenine dinucleotide
phosphate
NADH:NAD+¼ ratio of the reduced and oxidized forms,
respectively, of nicotinamide adenine
dinucleotide
NADPH:NADP+¼ ratio of the reduced and oxidized forms,
respectively, of nicotinamide adenine
dinucleotide phosphate
NEM¼N-ethylmaleimide
NFjB¼ nuclear factor NF-kappa-B p100 subunit
NOX¼NADPH oxidase




pKa¼ acid dissociation constant
PPP¼ pentose phosphate shunt
PRDX¼ peroxiredoxin
PTM¼ post-translational modification
ROS¼ reactive oxygen species
TRX¼ thioredoxin
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